$KEY Cashflow Statement | Understand Stock

$KEY

$21.20 +$0.05 (0.24%) Close

$KEY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for credit losses
Depreciation, amortization, and accretion, net
Accretion of acquired loans
Increase in cash surrender value of corporate-owned life insurance
Stock-based compensation expense
Deferred income taxes (benefit)
Proceeds from sales of loans held for sale
Originations of loans held for sale, net of repayments
Net losses (gains) from sale of loans held for sale
Net losses (gains) and writedown on OREO
Net losses (gains) on leased equipment
Net securities and other investments losses (gains)
Net losses (gains) on sales of fixed assets
Net change in:
Trading account assets
Net transfer of loans held for sale
Accrued income and other assets
Accrued expense and other liabilities
Other operating activities, net

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
INVESTING ACTIVITIES
Purchases of intangible assets via acquisitions
Cash received (used) in acquisitions, net of cash acquired
Net decrease (increase) in short-term investments, excluding acquisitions
Purchases of securities available for sale
Proceeds from sales of securities available for sale
Proceeds from prepayments and maturities of securities available for sale
Purchases of held-to-maturity securities
Proceeds from prepayments and maturities of held-to-maturity securities
Net decrease (increase) in other investments
Proceeds from prepayments and maturities of other investments
Net decrease (increase) in loans, excluding acquisitions, sales, and transfers
Proceeds from sales of portfolio loans
Proceeds from corporate-owned life insurance
Purchases of premises, equipment, and software
Proceeds from sales of premises and equipment
Proceeds from sales of OREO
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

FINANCING ACTIVITIES
Net increase (decrease) in deposits
Net increase (decrease) in short-term borrowings
Net proceeds from issuance of long-term debt
Payments on long-term debt
Repurchases of long-term debt
Issuance of preferred shares
Open market common share repurchases
Employee equity compensation program Common Share repurchases
Common share purchases under ASR program
Net proceeds from reissuance of Common Shares
Net proceeds from Scotiabank investment
Cash dividends paid
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
NET INCREASE (DECREASE) IN CASH AND DUE FROM BANKS
CASH AND DUE FROM BANKS AT BEGINNING OF YEAR
CASH AND DUE FROM BANKS AT END OF YEAR
Additional disclosures relative to cash flows:
Interest paid
Income taxes paid
Noncash items:
Reduction of secured borrowing and related collateral
Loans transferred to portfolio from held for sale
Loans transferred to held for sale from portfolio
Loans transferred to other real estate owned
CMBS risk retentions
ABS risk retentions
Securities received as consideration

Comments